Liquid-liquid phase separation is thought to underly gene transcription, through the condensation of the large-scale nucleolus, or in smaller assemblies known as transcriptional hubs or condensates. However, phase separation has not yet been directly linked with transcriptional output, and our biophysical understanding of transcription dynamics is poor. Here, we utilize an optogenetic approach to control condensation of key FET-family transcriptional regulators, particularly TAF15. We show that amino acid sequence-dependent phase separation of TAF15 is enhanced significantly due to strong nuclear interactions with the C-terminal domain (CTD) of RNA Pol II. Nascent CTD clusters at primed genomic loci lower the energetic barrier for nucleation of TAF15 condensates, which in turn further recruit RNA Pol II to drive transcriptional output. These results suggest a model in which positive feedback between key transcriptional components drives intermittent dynamics of localized phase separation, to amplify gene expression.
Transcriptional condensates and other nuclear bodies are enriched in nucleic acidbinding proteins containing large intrinsically disordered proteins or regions (IDPs/IDRs), closely related to low complexity sequences (LCS) and prion-like domains (PrLD). The amino acid sequences of IDRs encode an intrinsic preference for conformational heterogeneity and do not fold into a single three-dimensional structure. IDRs have been shown in numerous studies to promote phase separation [15] [16] [17] [18] [19] , although how specificity emerges from their sequence-encoded interactions is still largely unclear.
Of particular interest are members of the FET protein family, consisting of the proteins FUS (fused in sarcoma or translocated in liposarcoma), EWS (Ewing's sarcoma), and TAF15 (TATA-binding protein-associated factor 2N), which play roles not only in transcription but also in pre-mRNA splicing, DNA repair, and mRNA transport in neurons 20 . FUS, EWS, and TAF15 all contain an N-terminal IDR enriched in uncharged polar amino acids and aromatic amino acids ( Fig. S1) , an RNA-binding motif (RNA-recognition motif, RRM), and a R/G (arginine/glycine)-rich domain (Fig. 1A ). While recent in vitro studies have begun to explore the role of these amino acids in defining molecular interactions and specificity [21] [22] [23] , this remains poorly understood, particularly within living cells. Moreover, whether and how sequence-encoded phase behavior can determine functional transcriptional outputs, and their reported intermittent dynamics 24 , remains to be tested.
Results

Molecular interaction strength drives intracellular phase behavior
The valence of IDR-rich proteins is often enhanced through binding to multiple genomic elements 17, 18 , or through direct oligomerization 25 . To address the question of the sequencedependent transcriptional function of FET family proteins, we took advantage of the recently developed optoDroplet system 26 , which utilizes blue-light controlled oligomerization of the Cryptochrome 2 (Cry2) protein to control IDR oligomerization, and thus drive phase separation 20, 27 . In agreement with earlier work, we find that blue light drives phase separation of an optoFUS construct into liquid-like droplets in both the cytoplasm and nucleoplasm of NIH 3T3 cells ( Fig. 1B and Fig. S2 ). Consistent with the physics of classical phase separation, blue lightilluminated cells expressing different optoFUS concentrations reveal that the cytoplasmic concentration (Ccyto) begins to plateau at a saturation concentration (C * ) at roughly C * Cyto= 2.4 ± 0.4 μM (Fig. 1C ). We observe similar behavior with an optoEWS construct and an optoTAF15 construct, which consist of Cry2 fused to the IDR/LCS regions of EWS and TAF15, respectively (Fig. 1C) . Interestingly, however, optoTAF15 only phase separates in the cytoplasm at significantly higher concentrations, C * Cyto = 8.0 ± 0.6 μM, which is roughly 3-fold higher than the saturation concentration for nucleoplasmic optoTAF15 (2.6 ± 0.5 μM; Fig. 1D ). Thus, nucleoplasmic optoTAF15 has a significantly enhanced tendency to phase separate in the nucleoplasm compared to the cytoplasm, whereas other constructs tested exhibit only moderate differences between the cytoplasmic and nucleoplasmic saturation concentration ( Fig. 1D , inset).
To examine the biophysical origins of this surprising TAF15 phase behavior, we utilize fluorescence correlation spectroscopy (FCS) to estimate molecular interaction strength. An effective interaction strength, β, is determined by measuring protein diffusivity as a function of protein concentration, and analyzing the data using the relation D = D0 (1 + βC) (Eqn. 1) where D is protein diffusivity, D0 is the diffusivity at infinite dilution, and C is the protein concentration 28, 29 . In the absence of blue light illumination, optoTAF15 diffusivity decreases with increasing protein concentration ( Fig. 1E ), which indicates an attractive molecular interaction. However, optoTAF15 exhibits significantly stronger interactions in the nucleoplasm compared to the cytoplasm (i.e. Nuc is more negative than Cyto). OptoFUS also has slightly stronger interactions in the nucleoplasm, but not nearly as large as for optoTAF15. OptoEWS and a control construct optoDDX4 both exhibit no significant difference between their cytoplasmic and nucleoplasmic interaction strengths ( Fig. 1E inset) . For all constructs tested, the apparent molecular interaction strength in the absence of blue light illumination can be plotted against the saturation concentration for optoIDRs under blue light illumination, yielding a common intracellular phase boundary (Fig. 1F ). These findings suggest that IDR-driven phase separation exhibits remarkably universal features, and that the enhanced tendency for optoTAF15 to phase separate in the nucleoplasm compared with the cytoplasm reflects its correspondingly stronger intermolecular interactions there ( Fig. 1E and 1F ).
Transcriptional condensates colocalize with and recruit unphosphorylated CTD
We next sought to understand the origin of TAF15's increased interaction strength and preferential condensation in the nucleoplasm. TAF15 is a key transcriptional regulator and has been shown to interact with the C-terminal domain (CTD) of Pol II 27, 30 . We co-expressed the optoIDR constructs along with EGFP-tagged Pol II CTD construct consisting of a 52-repeat of the heptad consensus amino acid sequence YSPTSPS. We find that optoTAF15 droplets exhibit a nearly 4-fold preferential partitioning of CTD ( Fig. 2A and 2B ). As a negative control, there is no preferential partitioning of EGFP-CTD into induced optoDDX4 droplets. OptoEWS droplets similarly exhibit no CTD recruitment, while optoFUS exhibits a 2-fold enrichment of CTD ( Fig. 2A  and 2B ).
TAF15 exhibits a distribution of charged amino acid residues along its IDR, notably arginine (R), which is known to interact with tyrosine (Y) residues on CTD through cation-π interactions, and negatively charged aspartic acid (D), which electrostatically interacts with lysine (K) on CTD 30 . To test those interactions, we mutated optoTAF15 (optoTAF15-10RD) to reduce its charge by replacing arginine (R) with glutamine (Q), and aspartic acid (D) with serine (S) ( Fig. S1 ). CTD partitioning is significantly diminished in the charge-reduced optoTAF15-10RD droplets ( Fig. 2A and 2B) . Moreover, the optoTAF15-10RD construct has a significantly weakened tendency to phase separate, as indicated by its higher saturation concentration in nucleoplasm ( Fig. 2C ). Taken together, these data suggest that charge-mediated interactions between TAF15 and CTD contribute to TAF15's preferential condensation in the nucleoplasm.
Pol II CTD is known to undergo cycles of post-translational modifications to regulate transcriptional activity, including phosphorylation 27 , which alters charge-mediated interactions. Among these regulators is CDK7, a key kinase which negatively regulates the ability of CTD to function as a transcriptional scaffold 31 . To test whether the phosphorylation state of CTD influences optoTAF15's propensity to phase separate, we utilized the CDK7 inhibiting drug THZ1 32, 33 . We find that THZ1 treatment decreases the nucleoplasmic saturation concentration of optoTAF15, suggesting unphosphorylated CTD more strongly interacts with optoTAF15 to promotes its phase separation. Consistent with this interpretation, no significant change in the optoTAF15 saturation concentration is observed in the cytoplasm, where CTD is absent ( Fig.  2C ). Moreover, the partition coefficient of CTD into nuclear droplets strongly correlates with the difference between nucleoplasmic and cytoplasmic saturation concentrations ( Fig. 2D ). Thus, the degree of CTD phosphorylation modulates phase separation of transcriptional IDRs in the nucleus, and this effect correlates with the apparent interaction between CTD and the transcriptional IDRs.
Pol II CTD clusters impact the nucleation kinetics of transcriptional condensates
We reasoned that this tendency for CTD to enhance phase separation of TAF15 should exhibit strong spatial variability, as Pol II is not evenly distributed throughout the nucleoplasm, but instead is enriched in transcriptionally active regions 34, 35 . To examine whether optoTAF15 constructs exhibit any pattern to where and when they condense, we performed blue light cycling experiments where TAF15 condensates are induced to repeatedly phase separate, dissolve, and then again phase separate. We found that some of the optoTAF15 condensates reform in the same physical locations, but that these repetitively forming droplets are transient, and after several cycles they no longer form ( Fig. 3 A and 3B ). This behavior is in marked contrast to control optoDDX4 droplets, which appear at random locations where they were not found in previous cycles ( Fig. S3 ). To test whether stabilizing endogenous Pol II clusters would alter optoTAF15 behavior in cycling experiments, we treated cells with actinomycin D (Act D), a drug that blocks transcriptional elongation and thus locks Pol II at its promoter-proximal pausing stage 36, 37 . Act D-treated cells show repetitive localization of optoTAF15 to the same locations in subsequent light illumination cycles, consistent with Pol II remaining locked at high concentrations around specific transcriptional loci, thereby acting as stable nucleation sites for optoTAF15 condensation ( Fig. 3C and 3D ).
To further examine the hypothesis that native Pol II clusters provide high concentration CTD seeds that nucleate TAF15-rich condensates, we used an engineered system that stably localizes CTD to telomeres, by fusing the telomere associated protein TRF1 to EGFP-CTD (TRF1-CTD). As expected, TRF1-CTD appears as bright puncta, localized at telomeres. In light cycling experiments, the optoTAF15 condensates induced at telomeres always assemble and dissolve at the same locations; unlike the dynamic endogenous Pol II clusters, these engineered CTD foci provide long-term stable nucleation sites for optoTAF15 ( Fig. 3E and 3F ).
Classical nucleation theory describes how localized "seeds" can decrease the energetic barrier to nucleation, and thus increase nucleation rate (or decrease the delay time until nucleation onset) 38 . To quantitatively test this prediction of nucleation kinetics, we measured the nucleation delay time (dt), and find that optoTAF15 at TRF1-CTD clusters nucleates significantly faster than optoTAF15 condensates that form elsewhere in the nucleus ( Fig. 3G and 3H). The delay time of optoTAF15 condensates formed in these cells away from the TRF1-CTD clusters is similar to that of condensates forming in non-TRF1-CTD expressing cells ( Fig. 3 I) , dt= 59.9 ± 9.2, and dt= 52.1 ± 13.0 second, respectively. By contrast, the delay time distribution around TRF-CTD clusters are shifted to significantly lower times, dt= 32.4 ± 9.4 second. Moreover, consistent with classical nucleation theory, the delay time is inversely correlated to the concentration of TRF1-CTD clusters, with the brightest clusters nucleating optoTAF15 droplets in 24.7 ± 4.7 second (Group I, Fig. 3J ); the dimmest TRF1-CTD clusters nucleate optoTAF15 droplets in 40.8 ± 11.4 second (Group III, Fig. 3J ), approaching the long delay times measured for non TRF1-CTD seeding. These results provide further quantitative evidence that clusters of Pol II can modulate and localize the kinetic nucleation of TAF15 condensation (Fig.  3K ).
Condensation of FET-family IDRs enhance transcription
TAF15 is a transcriptional activator, and we wondered whether condensation of optoTAF15 droplets and associated partition of additional of Pol II would impact transcriptional activity. To test this hypothesis, we used 5-ethynyl uridine (EU, a uridine analog) to label nascent RNA transcripts and quantify their spatial location and amount. In cells expressing optoTAF15, but kept in the dark, few nuclei exhibited detectable EU puncta, but instead the EU signal was distributed evenly throughout the nucleoplasm (Fig. S4 ). By contrast, in blue lightilluminated optoTAF15 cells, an enriched EU signal was detected within optoTAF15 condensates ( Fig. 4A and 4B ). This enhanced EU signal is due to nascent transcription and is not an artifact of the optoIDR constructs, as no localized EU puncta were detected in cells treated with Act D to inhibit transcription elongation ( Fig. S4 ). Moreover, no puncta were observed in blue lightinduced optoDDX4 droplets ( Fig. 4A and 4B ). OptoEWS and optoFUS showed only a weak EU signal ( Fig. 4A and 4B ), consistent with our measurements of their weaker CTD recruitment ( Fig.  2B ). Remarkably, this ability of optoTAF15 condensates to enhance local transcription was also observed in telomere-tethered EGFP-CTD cells (Fig. S4 ); while telomeres are generally considered transcriptionally quiescent, telomeric repeat-containing RNA (TERRA) is known to be transcribed at telomeres 39 , and this enhanced EU signal at telomeres could reflect local enhancement of TERRA transcription (Fig. S4 ).
Discussion
In a number of different experimental systems, transcriptional activity has been found to exhibit intermittent activation 24, 40 , with bursts of transcription followed by periods of quiescence. We propose that these intermittent dynamics arise from the "all-or-none" nature of nucleated phase separation. Indeed, our data shows that even in nuclei supersaturated with TAF15, phase separation at a particular genomic location only occurs if the nucleation barrier is overcome; however, OptoTAF15 condensates undergo repeated nucleation at the same location for a limited duration, suggesting that the seeding CTD clusters exist only temporarily. Thus, initial accumulation of CTD at a locus can act as a seed for TAF15 condensate nucleation, subsequently driving additional CTD recruitment. Upon transcriptional elongation and native regulation by CDK7, the CTD of endogenous polymerase is phosphorylated and can no longer interact strongly with TAF15. Ultimately, the balance tips, phosphorylation and dispersal of CTDs results in lowered recruitment of TAF15, the condensate dissolves, and the transcriptional burst stops. Upon recruitment of a new Pol II CTD seed, TAF15 and other transcriptional condensates again can be nucleated to repeat the amplification and transcriptional bursting cycle (Fig. 4C) .
Our study to quantify intracellular phase diagrams and nucleation kinetics of transcriptional condensates is only the beginning of the union of fundamental biophysics and transcriptional regulation. Future work will move towards precise understanding of the endogenous energetic barrier that must be overcome to initiate transcriptional bursts at single loci, and will model the interplay with non-equilibrium driving forces impacting global transcriptional dynamics.
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Materials and Methods
Mammalian cell culture NIH 3T3 and Lenti-X 293T cells were cultured in growth medium (DMEM, GIBCO) supplemented with 10% FBS (Atlanta Biological) and penicillin and streptomycin (GIBCO) at 37°C with 5% CO2 in a humidified incubator.
Plasmid construction DNA fragments encoding human TAF15N (IDR of TAF15, residues 1-208), human TRF1 (both from our previous study (1)), CTD of the largest subunit of human RNA polymerase II (RPB1, Addgene 35175) and EGFP (Addgene 122147) was amplified by PCR using Phusion High-Fidelity DNA Polymerase (NEB). DNA fragments for the IDR of EWS (residues 47-266) and TAF15N-10RD were synthesized (Integrated DNA Technologies). Plasmids for OptoFUS containing IDR of human FUS (residues 1-214) and optoDDX4 containing IDR of DDX4 (residues 1-236) were generated in our previous study (2) and are available through Addgene (101223 and 101225). The sequences of IDRs used in this study are shown in Fig. S1 .
All constructs were cloned into pHR-based vector. For optoIDR constructs (IDR-fusion Cry2 plasmids), DNA fragments encoding the IDRs were inserted into the linearized pHR-mCh-Cry2WT (from our previous study (2), Addgene 101221) cut with MluI-HF (NEB) and treated with Quick CIP (NEB). All DNA constructs were assembled using In-Fusion HD cloning kit (Clonetech) following manufacturer's instruction. Assembled products were transformed into Stellar competent cells (Clontech), from which single colonies were picked, grown in LB growth medium supplemented with Ampicillin overnight, and isolated (QIAprep spin miniprep kit, QIAGEN) following manufacturer instructions. All cloning products were confirmed by Sanger sequencing (GENEWIZ).
Construction of stable cell lines
To produce stable cell lines, lentivirus was produced by transfecting the transfer plasmids, pCMV-dR8.91, and pMD2.G (9:8:1, mass ratio) into Lenti-X 293T cells grown to approximately 70% confluency in 6-well plates. A total of 3 μg plasmid and 9 μL of FuGENE HD Transfection Reagent (Promega) were delivered into each well following manufacturer's instruction. After 2 days, supernatant containing viral particles was harvested and filtered with 0.45 m filter (VWR). NIH 3T3 cells plated at ~ 30% confluency in the 12-well plates were infected by adding 1 mL of filtered viral supernatant directly to the cell medium. Virus-containing medium was replaced with fresh growth medium 24 hours post-infection.
Sample preparation for live cell imaging Cells were plated on 35-mm glass-bottom dishes pre-coated with Poly-D-Lysine (MatTek) and grown typically overnight in normal growth medium to reach ~50% confluency.
For transcription inhibition experiments, Actinomycin D (Sigma-Aldrich) was dissolved in DMSO at 0.5 mg/mL and further diluted in growth medium to a final concentration of 5 µg/ml before being applied to NIH 3T3 cells followed by a 2-hour incubation prior to being imaged. For CDK7 inhibition experiments, THZ1 (Med Chem Express) was dissolved in DMSO at 1 mM and further diluted with growth medium to a final concentration of 1 M before being applied to NIH 3T3 cells followed by a 1.5-hour incubation prior to being imaged.
Nascent RNA transcripts labeling of cultured cells
To label nascent RNA transcripts in live cells, Click-iT RNA Alexa Fluor 488 Imaging Kit was used following protocol from the manufacturer with Alexa Fluor 647 azide from Click-iT EdU Alexa Fluor 647 Imaging Kit. Cells seeded in a 35-mm glass bottom dish were first illuminated by blue light for 15 minutes before 5-ethyl uridine (EU) was added and incubated for 15mins under blue-light illumination. 8 L of 100 mM EU stock solution was added into each dish containing 2 mL growth medium to obtain a final concentration of 0.4 μΜ. After EU labeling, cells were first washed with PBS, and then fixed and permeabilized using 3.7% formaldehyde and 0.5% Triton X-100 in PBS, respectively, for 15 minutes each at room temperature, and washed again with PBS. Next, Alexa Fluor 647 conjugation was carried out by adding 500 L of Click-iT reaction cocktail containing Alexa Fluor 647 azide to each dish; samples were then incubated for 30 minutes at room temperature without blue light before being washed with Click-iT reaction rinse buffer and PBS. Finally, DNA was stained with Hoechst 33342 (10 g/mL in PBS) for 15 minutes at room temperature and samples were washed twice with PBS prior to imaging.
RNA fluorescence in situ hybridization RNA fluorescence in situ hybridization (FISH) experiments were performed following protocols from Biosearch Technologies with some modifications. Cells were incubated at 37 °C for 30 minutes with or without blue light illumination and fixed with 4% paraformaldyhyde in PBS at room temperature for 10 minutes. Cells were then permeabilized with 70% ethanol at room temperature for 1 hour and pre-equilibrated with Buffer A (0.2X Stellaris RNA FISH Wash Buffer A and 10% formamide in PBS) at room temperature for 5 minutes. To probe TERRA RNA, hybridization was carried out using 0.125μM DNA probe of the following sequence: 5'-TAACCCTAACCCTAACCCTAACCCTAACCCTAACCCTAACCC-/3Cy5Sp/-3' (/3Cy5Sp/ indicates 3'-end Cy5 modification) in Stellaris RNA FISH Hybridization Buffer with 10% formamide in a humidified chamber incubated at 37°C overnight. Samples were then washed twice with Buffer A at 37°C for 30 minutes; 5 μg/mL DAPI was included during the second wash. Then cells were washed with Stellaris RNA FISH Wash Buffer B at room temperature for 5 minutes. Finally, anti-fade reagent Vectashield was added and the samples were covered by cover-glass and sealed with nail polish. Samples were stored in 4°C for one day before being imaged.
Microscopy
All images were taken using 60X immersion objective (Plan Apo 60X/1.4, Nikon) on a Nikon A1 laser scanning confocal microscope. An imaging chamber was maintained at 37°C with 5% CO2. For activation, cells were usually imaged with 440-nm laser with a dichroic filter for the 488-nm laser in order to attenuate blue laser intensity at the specimen plane below 0.4 W.
For studying light-activated phase behavior, the activation protocol was performed with 440nm laser every second and fluorescent image of mCherry was acquired with 568-nm laser every 10 seconds, with pin hole size set to 33.2 m, frame size to 512x512 pixel-square, and dwell time to 2.2 s. For each cycle of a multi-cycle activation, the above activation protocol was applied for 1 minute, followed by a 9-minute deactivation (acquisition of mCherry fluorescent image every 10 seconds); this cycle was repeated for 8 times.
For delay time of initial nuclearization measurement, activation protocols were performed with 440 nm per each 10 second and with 568 nm per each second to observe mCherry channel with pin hole size set to 33.2 m, 512x512 pix frame sizes, and 2.2 s dwell time.
To observe multi-channel image, 667-nm, 568-nm, 488-nm, and 405-nm lasers were used to excite Alexa Fluor 647, mCherry, EGFP, and DAPI (or Hoechst 33342) in cells, respectively.
Fluorescence Correlation Spectroscopy
We used a laser scanning confocal microscope (Nikon A1; an oil immersion objective, Plan Apo 60X/1.4, Nikon) combined with Fluorescence Correlation Spectroscopy (FCS) Upgrade Kit for Laser Scanning Microscopes (PicoQuant). FCS measurements were performed using the SymPhoTime Software (PicoQuant). Data for diffusion and concentration of proteins were obtained with 30 s of FCS measurement time. For each measurement, the resulting autocorrelation functions were fitted with the pure diffusion model. The measurement volume was determined by fluorophore dye Atto 550 in water (ωxy = 0.18 m and the ratio of axial to radial of measurement volume, κ = ωz/ωxy = 5.1). Here, in living cells, the refractive index mismatch that can distort the FCS measurement volume as a non-Gaussian profile as well as other optical artifacts would lead to an absolute error of ~20% in diffusion coefficient and concentration (3) .
The dependence of the diffusivity (D) on protein concentration (C) can be written as: D = D0 (1 + βC), where D is protein diffusivity, D0 is the diffusivity at infinite dilution, β is interaction strength, and C is the protein concentration. β can be written as: (2B2M − ks − ) Mc, where M is the molecular weight, B2 is the second virial coefficient, ks is sedimentation interaction parameter,  is partial specific volume, and c is protein weight concentration (4). Mean and standard deviation of diffusion coefficient and concentration were inferred from fitting correlation curves from 5-10 different cells. β was calculated by taking the slope of the fitted lines of diffusion coefficient vs. concentration for each cell line.
Image analysis of molecular concentrations
Total concentrations of molecules as well as steady-state background concentrations outside clusters were measured from fluorescence images of cells using ImageJ (NIH), and corrected by subtracting background noises measured with areas devoid of any cells. Cells expressing optoIDRs rapidly assemble optoDroplets under blue light illumination as shows in Fig. S2 .
Colocalization analysis
The colocalization coefficient between two-color images was estimated by calculating Pearson's correlation coefficient (PCC) defined as;
, where x and x are the i pixel intensity and mean values in the segmented color 1 image, respectively. Likewise, y and y are the i pixel intensity and mean values in the color 2 image, respectively. The perfect-correlation, no-correlation, and anti-correlation give the values of PCC = 1, 0, -1, respectively. The correlation in the whole nucleus (except for nucleoli) was calculated (5) .
Fig. S1. The amino acid sequence of intrinsically disordered regions. Polar residues are shown in green; positively charged are shown in blue; negatively charged are shown in red; hydrophobic are shown in black; aromatic residues are shown in orange.
Fig. S2
Rapid clustering of optoIDRs upon blue light illumination. Images of optoIDRs cells exposed by blue light illumination. Time since the start of illumination is shown with 0 sec indicating before illumination. The protein concentration was determined by the fluorescence intensity outside of clusters. The concentration was measured during clustering until it reaches steady state.
Fig. S3
Repeated assemble and disassemble of optoDroplets. (A) OptoDDX4 and TRF1-CTD cells, (B) Act D treated optoTAF15 cells, and (C) optoTAF15 and TRF1-CTD cells were exposed to blue light activation condition for 1 min to assemble clusters and then incubated in the absence of blue light for 9 min to disassemble clusters. Cell images before and after activation at the end of each cycle are shown. (D) OptoTAF15 and TRF1-CTD cells were exposed to continuous blue light illumination. OptoTAF15 condensates remain stable at telomere tethered CTD sites. Scale bars, 5m. 
